Company Profile

Viatech Imaging LLC (AKA: Cognetix, Inc)
Profile last edited on: 10/17/16      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

Box 456 158 Main Street
Ivoryton, CT 06442
   (860) 767-7101
Location: Single
Congr. District: 02
County: Middlesex

Public Profile

Before its acquisition in 1998 by Cognetix - itself an SBR involved firm that took over the work onthe Viatech awards, Viatech had been involved in high-throughput functional screening with advanced systems for cell-based assays. Viatech's two senior scientists joined Cognetix in conjunction with the acquisition. Ann Cornell-Bell, Ph.D., formerly of Yale University School of Medicine and a pioneer in the use of confocal microscopy for cell imaging, assumed the post of Director of Drug Discovery. Leslie Riblet, Ph.D., who played key roles in central nervous system drug discovery and development at Bristol-Myers Squibb, joined the Company as Director of Drug Development.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2000 2 NIH $900,000
Project Title: In Vitro Fluoro-Test for Environmental/Agrochemical

Key People / Management

  Leslie Ribet -- President

  Ann H Cornell-Bell